Placebo-controlled trial of moclobemide in social phobia

Moclobemide, a reversible inhibitor of monoamine oxidase A, previously has been reported to have efficacy in the treatment of social phobia. Seventy-seven non-responders to one week of single-blind placebo were randomly assigned to moclobemide or placebo for eight weeks of double-blind treatment. Ou...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of psychiatry 1998-01, Vol.172 (1), p.70-77
Hauptverfasser:	Schneier, Franklin R., Goetz, Deborah, Campeas, Raphael, Marshall, Randall, Fallon, Brian, Liebowitz, Michael R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Amine oxidase (flavin-containing) Anxiety Benzamides - adverse effects Benzamides - therapeutic use Clinical trials Double-Blind Method Efficacy Fear & phobias Female Humans Male Middle Aged Moclobemide Monoamine Oxidase Inhibitors - adverse effects Monoamine Oxidase Inhibitors - therapeutic use Phobic Disorders - drug therapy Prospective Studies Reversible Social anxiety Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!